Cite
APA Citation
Nozaki, Y., Inoue, A., Kinoshita, K., Funauchi, M., & Matsumura, I. (2020). efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis. Modern rheumatology, 30(2), 249–258. http://access.bl.uk/ark:/81055/vdc_100101889208.0x000023